ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $81,281 | -19.7% | 40,040 | -9.0% | 0.05% | -18.3% |
Q2 2023 | $101,255 | -10.2% | 44,024 | +18.4% | 0.06% | -3.2% |
Q1 2023 | $112,707 | -6.1% | 37,197 | -27.8% | 0.06% | -1.6% |
Q4 2022 | $119,986 | +46.3% | 51,496 | +19.8% | 0.06% | +90.9% |
Q3 2022 | $82,000 | -29.3% | 42,988 | +0.7% | 0.03% | -23.3% |
Q2 2022 | $116,000 | +3.6% | 42,675 | +14.0% | 0.04% | -14.0% |
Q1 2022 | $112,000 | -27.3% | 37,448 | -5.6% | 0.05% | -13.8% |
Q4 2021 | $154,000 | -31.6% | 39,675 | -27.2% | 0.06% | -81.3% |
Q1 2016 | $225,000 | – | 54,471 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
LMR Partners LLP | 107,912 | $196,000 | 0.01% |
Virtu Financial LLC | 17,147 | $31,000 | 0.00% |